89BIO, INC. (ETNB): Price and Financial Metrics
ETNB Price/Volume Stats
| Current price | $7.78 | 52-week high | $11.84 |
| Prev. close | $7.64 | 52-week low | $4.16 |
| Day low | $7.46 | Volume | 1,051,700 |
| Day high | $7.87 | Avg. volume | 2,222,376 |
| 50-day MA | $7.39 | Dividend yield | N/A |
| 200-day MA | $8.20 | Market Cap | 1.14B |
ETNB Stock Price Chart Interactive Chart >
89BIO, INC. (ETNB) Company Bio
89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.
ETNB Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | -2.63% |
| 1-year | -9.85% |
| 3-year | 160.20% |
| 5-year | -70.52% |
| YTD | -0.51% |
| 2024 | -29.99% |
| 2023 | -12.25% |
| 2022 | -2.60% |
| 2021 | -46.37% |
| 2020 | -7.30% |
Loading social stream, please wait...